Review of: "Design and Molecular Screening of Various Compounds by Molecular Docking as BACE-1 Inhibitors"

Résumé

Reviewer commentIn this study, the authors use molecular docking to study the interaction of quercetin, myricetin, & baicalein, ferulic acid, and donepezil with the BACE-1 protein and found that these compounds exhibit binding affinity, showing that they can fit better in the active site of BACE-1.According to the authors, these findings represent a major breakthrough in Alzheimer's disease research.This paper appears to be interesting but needs a major revision.It cannot be accepted in its current form; therefore, further corrections are required following the comments listed below :1.In the introduction, I understand that the authors want to clarify the β-amyloid hypothesis by using the colon; I would

Citer ce document

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0